Biotechnology Innovation Organization

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

The Biotechnology Innovation Organization (BIO) is the largest trade organization in the world that represents the biotechnology industry.[1][2][3] On January 4, 2016 the Biotechnology Industry Organization changed its name to be the Biotechnology Innovation Organization.[4][5]

Biotechnology Innovation Organization
Formerly called
Biotechnology Industry Organization


Trade meetings[edit]

BIO holds a trade meeting each year in the United States, which are essential for the business development and partnering activities that are required in the biotechnology sector, in which it is expensive to develop products, timelines to develop products are long, and regulatory risks are high.[6] In 2018 the BIO International Convention was held in Boston and was attended by 18,289 delegates from 49 states, the District of Columbia and Puerto Rico and 67 countries.[7] The event also held over 46,916 One-On-One Partnering Meetings, becoming a Guinness World Records, Record Holder for the "Largest Business Partnering Event."[8][9]

It also holds regional partnering meetings, for example in China,[10] India,[11] and Europe.[12]


In 2013 it spent $1.98 million on lobbying in the United States.[13] Issues included the amending the Internal Revenue Code to provide an exception from the passive loss rules for investments in high-technology research small business pass-through entities, to include vaccines against seasonal influenza within the definition of taxable vaccines, and to extend, expand, and improve the qualifying therapeutic discovery project program that first became law in 2010.[14][15]

Examples of its public lobbying efforts, include support for development of biofuels such as those produced from algae,[16] genetically modified crops,[17] strong intellectual property rights,[18] and for a more efficient and predictable regulatory process for new food and drug products.[19]


In June 2013 BIO partnered with the Coalition of Small Business Innovators to lobby the U.S. government to modernize the U.S. tax code "to recognize and promote small business innovation as fundamental to the long-term growth of the U.S. economy".[20][21]

It is a member of The Alliance to Feed the Future, an umbrella network, the mission of which is to "raise awareness and improve understanding of the benefits & necessity of modern food production and technology in order to meet global demand".[22][23]

Industry initiatives[edit]

The "Right Mix Matters" campaign launched in 2019 targets diversity within biopharmaceutical company leadership, including ongoing assessment of diversity measures (gender, race, ethnicity, sexual orientation) and the provision of online tools aimed at assisting companies to achieve target diversity goals.[5]



James C. Greenwood, President of BIO, 2017

BIOs members include companies that make Pharmaceutical drugs, biofuels, industrial enzymes, and genetically modified crops.[24] As of 2016, it represents 1,100 biotech companies in all 50 U.S. states, which employ 1.61 million Americans and support an additional 3.4 million jobs.[20]


BIO was founded 1993 in Washington, D.C. and Carl B. Feldbaum was the president from BIO's founding until he retired in 2004,[25] and was succeeded by James C. Greenwood Leadership of BIO is vested in a 100+ member board.[5] As of 2019, John Maraganore, PhD., president and chief executive officer of Alnylam Pharmaceuticals, Inc., was chairman,[5][26] and James Greenwood was president and CEO.[27] Ron Cohen, CEO of Acorda, preceded Maraganore as chair, elected to the position in June 2015.[5]

Biotechnology Heritage Award[edit]

The Biotechnology Heritage Award, presented annually at the Biotechnology Innovation Organization (BIO) Annual International Convention by the Biotechnology Innovation Organization (BIO) and the Science History Institute (formerly the Chemical Heritage Foundation), recognizes individuals who have made significant contributions to the development of biotechnology through discovery, innovation, and public understanding.[28]


  1. ^ Anna Edney, "Biosciences Defy U.S. Jobs Slump as Research Labs Hire", Bloomberg News, June 19, 2012.
  2. ^ European Biotechnology Network. "List of European and International Biotech Industry Associations" Archived 2019-01-29 at the Wayback Machine
  3. ^ "GEN's 30th Anniversary: Biotech Trade Associations", Genetic Engineering News, June 15, 2011.
  4. ^ "Biotechnology Innovation Organization changes name to Biotechnology Innovation Organization" (Press release). BusinessWire. 4 January 2016. Retrieved 4 July 2019.
  5. ^ a b c d e Wright, Rob (1 July 2019). "Increasing Diversity Among Leadership And Boards". Life Science Leader. VertMarkets.
  6. ^ Robert Weisman, "Biopharmaceutical industry faces a shift in dynamics", Boston Globe, April 23, 2013.
  7. ^ BIO Press Office. June 7, 2018 BIO2018: By The Numbers
  8. ^ "BIO Sets the GUINNESS WORLD RECORDS™ Title for the Largest Business Partnering Event - BIO". BIO. Retrieved 2018-07-02.
  9. ^ "BIO 2018: By the Numbers | 2018 BIO International Convention". Retrieved 2018-07-02.
  10. ^ "The Biotechnology Innovation Organization (BIO) and the China Center for Pharmaceutical International Exchange (CCPIE) Announce Strategic Partnership to Expand the BIO Convention in China" Archived 2016-03-06 at the Wayback Machine, BIO Press Office. April 18, 2013
  11. ^ "BIO India Conference showcases growing Indian biotech industry", BIO Press Release. September 7, 2010.
  12. ^ Staff, Flanders BIO. "BIO-Europe® 2013 - 19th Annual International Partnering Meeting" Archived 2016-06-10 at the Wayback Machine
  13. ^ Staff, The Center for Responsive Politics. "Lobbying: Biotechnology Innovation Organization", Page Accessed June 7, 2013
  14. ^ The Center for Responsive Politics, "Bills lobbied", Page Accessed June 7, 2013
  15. ^ Drew Armstrong, "Promising' Biotechnology Medicines May Earn $5 Million U.S. Tax Credit", Bloomberg News, May 21, 2010.
  16. ^ Kambiz Foroohar for Bloomberg News. June 3, 2010. Exxon $600 Million Algae Investment Makes Khosla See Pipe Dream
  17. ^ Elaine Watson, "It's not too late to change the conversation on GMOs: Interview with Cathy Enright, Executive VP for Food and Biotechnology, BIO", Food Navigator, May 20, 2013.
  18. ^ Victoria Slind-Flor, "LG, DuPont, Bank of America, GM: Intellectual Property", Bloomberg News, December 3, 2012.
  19. ^ Robert Weisman, "Federal drug review nettles biotech industry", Boston Globe, June 19, 2012.
  20. ^ a b "Biotechnology Innovation Organization Joins Coalition of Small Business Innovators" Archived 2014-11-04 at the Wayback Machine, BIO Press Release, June 4, 2013.
  21. ^ ""Coalition of Small Business Innovators Official Website"". Archived from the original on 2017-09-30. Retrieved 2016-01-04.
  22. ^ Alliance to Feed the Future Official Website Archived May 11, 2013, at the Wayback Machine
  23. ^ PR Web. Monday, March 18, 2013 "Alliance to Feed the Future Congratulates Our Farmers, Supports Education for Future Generations on National Agriculture Day"
  24. ^ ""BIO profile at Biospace"". Archived from the original on 2017-10-13. Retrieved 2016-01-04.
  25. ^ "BIO President Carl Feldbaum to Retire at Year End" (Press release). Biotechnology Innovation Organization. 2 February 2004. Retrieved 15 July 2009.
  26. ^ "Our Leadership". Retrieved 2018-07-02.
  27. ^ Staff, BIO BIO Senior Staff Page Accessed June 7, 2013
  28. ^ "Biotechnology Heritage Award". Science History Institute. Retrieved 21 February 2018.

External links[edit]